Boston Scientific Corp (NYSE:BSX)
| 39.52 Delayed Data As of 4:00pm ET |  -0.02 / -0.05%Today’s Change | 24.10 Today|||52-Week Range 42.37 | +9.93% Year-to-Date |
Latest BSX News | Press Releases
| Boston Scientific (BSX) Down 2.1% Since Last Earnings Report: Can It Rebound? Mar 05 / Zacks.com - Paid Partner Content | Here's Why You Should Hold on to Medtronic (MDT) Stock for Now Mar 03 / Zacks.com - Paid Partner Content |
| Boston Scientific (BSX) Buys Lumenis to Expand in Urology Mar 04 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 39.54 |
| Today’s open | 39.54 |
| Day’s range | 39.16 - 39.98 |
| Volume | 9,616,426 |
| Average volume (3 months) | 12,747,250 |
| Market cap | $56.0B |
Data as of 4:00pm ET, 03/08/2021
Growth & Valuation
| Earnings growth (last year) | -102.40% |
| Earnings growth (this year) | +59.98% |
| Earnings growth (next 5 years) | +9.00% |
| Revenue growth (last year) | -7.66% |
| P/E ratio | NM |
| Price/Sales | 5.14 |
| Price/Book | 3.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | -0.35 | -0.14% |
| BAXBaxter International... | +0.20 | +0.26% |
| DXCMDexcom Inc | -12.05 | -3.31% |
| ZBHZimmer Biomet Holdin... | -1.92 | -1.21% |
Data as of 4:00pm ET, 03/08/2021
Financials
| Next reporting date | April 28, 2021 |
| EPS forecast (this quarter) | $0.30 |
| Annual revenue (last year) | $9.9B |
| Annual profit (last year) | -$82.0M |
| Net profit margin | -0.83% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Marlborough, Massachusetts |
Forecasts
